- Home
- / ProKidney
ProKidney
Stock Price
$1.7
2024-10-29
Market Capitalization
$1.8 B
2024-10-29
ProKidney Summary
Company Summary
- Overview
- ProKidney is a biotechnology company that specializes in chronic disease treatment solutions. It develops Renal Autologous Cell Therapy (RMAT) solutions for treating chronic kidney disease (CKD).
- Type
- Public
- Status
- Active
- Website
- https://prokidney.com/
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026